Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LDN for QoL in High Grade Glioma
NCT01303835Phase 2Completed
- Sponsor
- Katy Peters
- Start
- May 2011
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of naltrexone in malignant glioma, sponsored by Katy Peters. Started May 2011; status: completed.
02
Drugs
naltrexone
03
Conditions
malignant glioma
Beyond the preview
Go deeper on NCT01303835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01303835.